Sesen Bio Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs) – Business Wire
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of…
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of…
The governing Connectivity Standards Alliance (CSA) announced today that the Google-backed Matter launch would be delayed…
The Westsea Towers apartment unit sold at its listed price.
The closure raises fears of new disruptions to world trade that could slow the global economy’s recovery.
Limited to 40 units.
Supercar maker Bugatti has turned a one-off experimental prototype into an extreme £5million limited edition hypercar for the…
Bugatti will build 40 of these track-day monsters.
Bugatti’s track-only study loses power and gains safety kit, but still looks an extraordinary way to spend £3.5m
Analysis – With the simple touch of a smartphone, online food delivery services conveniently offer takeaway food straight to…
Immunocompromised Americans are one step closer to getting additional vaccine protection after the CDC’s advisory panel voted unanimously on Friday